49 citations
,
April 2012 in “Phytotherapy Research”
This study found that topical Rosmarinus officinalis leaf extract improved hair regrowth in mice and inhibited androgen-associated mechanisms involved in hair loss.
This study found that 59.7% of lupus patients self-reported alopecia, which was linked to anti-Ro antibody presence and cutaneous SLE symptoms but not to age, ethnicity, or medication.
51 citations
,
May 2011 in “Phytotherapy Research”
This study suggests that red ginseng rhizome extracts, particularly ginsenoside Ro, may promote hair re-growth in an androgenetic alopecia model due to their inhibitory activity on testosterone 5α-reductase.
September 2019 in “Journal of Investigative Dermatology”
This study demonstrated that an RO formulation significantly improved neck wrinkles after 8 weeks of application, compared to a placebo, in Japanese female subjects.
59 citations
,
August 2003 in “Phytotherapy Research”
This study found that a 70% methanol extract from red ginseng stimulated hair growth in mouse vibrissal follicles, suggesting its bioactive components, particularly certain ginsenosides, may promote hair growth.
The user experienced significant hair regrowth after switching from fake to genuine minoxidil, alongside continued use of finasteride. They advise caution when purchasing minoxidil from Amazon due to the risk of counterfeit products.
The user shared their experience with various hair loss treatments, including Kirkland Minoxidil Foam, Happy Head Topical Fin and Min, Locklab, Ro Mane Spray, and plans to try Happy Head 10 in 1 serum. They found Happy Head Fin and Min effective for crown regrowth but are considering switching to Ro Mane or the new Happy Head serum for less greasiness and staining.
The conversation is about obtaining affordable hair loss treatments, specifically dutasteride and minoxidil, through Costco and other pharmacies without needing a membership. The user shares their experience of getting prescriptions from Dr. B’s and Ro, highlighting the cost-effectiveness of their regimen.
OP wants to increase pyrilutamide concentration from 0.5% to 1% while already using finasteride. Users suggest waiting for a commercial 1% solution and caution against using grey market products.
HopeMed is upset with Absci for allegedly using misleading information about HMI-115's performance compared to ABS-201. HopeMed plans to take legal action to protect its confidential data and trade secrets.